Latest filing published 20 Oct 2026 for 와이바이오로직스.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -77.9%Entry ₩34,650 · Close 19 Oct 2026 ₩7,650
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
박범찬: trading record in brief
박범찬 is a declared insider of 와이바이오로직스 (senior executive), with filings sourced from DART (FSS). In total, 4 filings cover trades dated from 18 December 2025 to 20 October 2026.
The open-market record is one-sided, with 3 purchases worth €300k and not one sale. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 2 purchases and no sales.
Most recently, on 20 October 2026, the filings show a transaction in 와이바이오로직스. The last insider purchase was made public on 14 October 2026, 25 days ago. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 박범찬
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0DART
- 1,425 sharesShareKRXDART:20261014000099Canonical exit: 12 Jan 2027 (T+90)
- 20,000 shares@ ₩25,691.000.34% mcap100.0% of flowShareKRXDART:20260319000817Canonical exit: 15 Jun 2026 (T+90)
- 20,000 sharesShareKRXDART:20251218000472Canonical exit: 18 Mar 2026 (T+90)
4 of 4 declarations